Betulinic acid-mediating miRNA-365 inhibited the progression of pancreatic cancer
Oncology Research · 2023
DOI: 10.32604/or.2023.026959 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Research, 2023. Verfasst von Xin Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The Second Hospital of Lanzhou University, Lanzhou, 730000, China. Hauptthemen laut MEDLINE: MicroRNAs, Triterpenes, Pancreatic Neoplasms, Immediate-Early Proteins. Die Arbeit wurde bisher 8-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, The Second Hospital of Lanzhou University, Lanzhou, 730000, China.
- The First Clinical Medical College, Lanzhou University, Lanzhou, 730000, China.
- The Second Clinical Medical College, Lanzhou University, Lanzhou, 730000, China.
Zitieren
APA
Li, X., Jiang, W., Li, W., Dong, S., DU, Y., Zhang, H., & Zhou, W. (2023). Betulinic acid-mediating miRNA-365 inhibited the progression of pancreatic cancer. Oncology Research. https://doi.org/10.32604/or.2023.026959
Vancouver
Li X, Jiang W, Li W, Dong S, DU Y, Zhang H, et al. Betulinic acid-mediating miRNA-365 inhibited the progression of pancreatic cancer. Oncology Research. 2023. doi:10.32604/or.2023.026959
BibTeX
@article{Li2023,
author = {Li, Xin and Jiang, Wenkai and Li, Wancheng and Dong, Shi and DU, Yan and Zhang, Hui and Zhou, Wence},
title = {Betulinic acid-mediating miRNA-365 inhibited the progression of pancreatic cancer},
journal = {Oncology Research},
year = {2023},
doi = {10.32604/or.2023.026959}
}
EUVIMED